Nexalin Technology, Inc.
- NXL
- NASDAQ
- Medical devices
- Neurostimulation Devices
- Mental Health Medical Devices
$2.35
Today −4.08%Quote Oct 16, 2026, 08:00 PM UTC
−53.91%over the last month
Max drawdown −68.9%From 1-month high −68.9%3 months −84.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$51.8M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.68
28.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NXLPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q4 2025 revenue $171,895
- Licensing Fee$31,80118.5%
- Equipment$16,7049.7%
- Other$15,8949.2%
- Other / not reported$107,49662.5%
Industry
Medical devices
Employees
8
Founded
2021